期刊文献+

芍药汤配合美沙拉嗪治疗溃疡性结肠炎疗效观察 被引量:1

Shaoyao Tang plus Mesalazine for Treating Ulcerative Colitis:Effect Observation
原文传递
导出
摘要 为观察中西药配合治疗溃疡性结肠炎(UC)的临床疗效,将120例溃疡性结肠炎患者随机分为对照组和观察组,每组各60例。对照组给予口服美沙拉嗪治疗,观察组在此基础上配合中药芍药汤口服。2周为1个疗程,3个疗程后比较两组疗效。结果显示,观察组的有效率(96.7%,58/60)显著高于对照组(63.3%,38/60),P〈0.05);对2组78例治愈患者随访1年,观察组复发率(22.2%,10/45)显著低于对照组(72%,18/25)(P〈0.05)。结果表明,芍药汤配合美沙拉嗪口服治疗溃疡性结肠炎较单纯美沙拉嗪口服治疗临床疗效更为显著,且复发率低。 This study was to observe the clinical effect of UC treated with integration of Chinese materia media with western ones,randomly divided 120 UC patients into control group and observation one,60 ca- ses for each ; the former orally administered masalazine, while based on masalazine the latter added Shaoyao Tang(a Chinese medicine decoction-formula),all lasted 3 treatment courses(2 weeks×3);then both group "s effects were compared.As results,the effective rate of the latter was significantly higher than that of the former(96.7%,58/60 vs 63.3%,38/60, P 〈0.05);after the follow-up of a year for 78 patients from 2 groups,the recurrence rate of the latter was signficantly lower than that of the former(22.2%, 10/45 vs 72%, 18/25, P 〈0.05).Results show that Shaoyao Tang plus masalazine has more effective outcome,and lower recurrence rate.
出处 《中国肛肠病杂志》 2016年第6期37-38,共2页 Chinese Journal of Coloproctology
关键词 溃疡性结肠炎 芍药汤 美沙拉嗪 Ulcerative colitis Shaoyao Tang Masalazine
  • 相关文献

参考文献2

二级参考文献24

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413.
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753.
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385.
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643.
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15.
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16.
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173.
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.

共引文献750

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部